Jackson, Grant Investment Advisers, Inc. Organon & Co. Transaction History

Jackson, Grant Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$30.45 - $39.36 $10,962 - $14,169	-360 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$28.67 - $37.13 $1,261 - $1,633	-44 Reduced 10.89%	360 $11,000
Q3 2021 Oct 13, 2021	SELL	$28.63 - $35.64 $19,210 - $23,914	-671 Reduced 62.42%	404 $13,000
Q2 2021 Jul 15, 2021	BUY	$28.45 - $38.0 $30,583 - $40,850	1,075 New	1,075 $33,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.